Adaptive Phase 1 Design in Radiation Therapy Trials
Article in International Journal of Radiation Oncology • Biology • Physics (July 2022)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Targeting Cullin-RING E3 Ligases for Radiosensitization: From NEDDylation Inhibition to PROTACs
Article in Frontiers in Oncology (August 2020)
Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy oncology trials as examples
Article in BMC Medical Research Methodology (June 2020)